Story excerpt provided by Crain’s Cleveland Business.
Written by Timothy Magaw.
Cleveland Clinic Innovations has spun-off its 71st company — Centerline Biomedical Inc., which plans to develop and commercialize a technology designed to reduce radiation exposure to patients and caregivers during endovascular procedures.
At present, endovascular surgeons rely on X-ray technology when putting instruments and other devices into position during surgeries, particularly those to repair endovascular aneurysms. The Clinic said the procedures last several hours, exposing the patients and surgeons to large amount of harmful radiation. Centerline’s proprietary 3D surgical platform, however, uses a GPS-like navigation tool that employs “a proprietary algorithm and sensor-equipped instrumentation,” which limits the radiation exposure, according to a news release.
Click here to read the complete article.
Originally published December 18, 2014.